You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-BCL2L1 antibody [E18] (ab32370)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-BCL2L1 antibody [E18]
See all BCL2L1 products (30) ...

Description

Rabbit monoclonal [E18] to BCL2L1

Specificity

This antibody should recognize Bcl-xL, Bcl-xS and Bcl-x(beta) as the immunogen sequence is common to them. The antibody does not cross-react with other Bcl-2 family members.

Tested applications

WB, IHC-P, ICC/IF, Flow Cyt, IPmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Predicted to work with

Pig

Immunogen

A synthetic peptide corresponding to residues between BH3 and BH4 of Human Bcl-x.

Positive control

Human prostate carcinoma tissue and K562 cells.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.01% Sodium Azide
Constituents: 40% Glycerol, 0.05% BSA, 0.15M Sodium chloride, 50mM Tris glycine. pH 7.4

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Monoclonal

Clone number

E18

Isotype

IgG

  • Western blot - Bcl x antibody [E18] (ab32370)Western blot - Bcl x antibody [E18] (ab32370) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - Bcl x antibody [E18] (ab32370)Immunohistochemistry (Paraffin-embedded sections) - Bcl x antibody [E18] (ab32370) image (enlarge)

  • Western blot - BCL2L1 antibody [E18] (ab32370)Western blot - BCL2L1 antibody [E18] (ab32370) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab32370 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Potent inhibitor of cell death. Inhibits activation of caspases (By similarity). Appears to regulate cell death by blocking the voltage-dependent anion channnel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane.
Isoform Bcl-X(S) promotes apoptosis.

Tissue specificity

Bcl-X(S) is expressed at high levels in cells that undergo a high rate of turnover, such as developing lymphocytes. In contrast, Bcl-X(L) is found in tissues containing long-lived postmitotic cells, such as adult brain.

Sequence similarities

Belongs to the Bcl-2 family.

Domain

The BH4 motif is required for anti-apoptotic activity. The BH1 and BH2 motifs are required for both heterodimerization with other Bcl-2 family members and for repression of cell death.

Post-translational
modifications

Proteolytically cleaved by caspases during apoptosis. The cleaved protein, lacking the BH4 motif, has pro-apoptotic activity.

Cellular localization

Mitochondrion membrane. Nucleus membrane. Mitochondrial membranes and perinuclear envelope.

Target information above from: UniProt accessionQ07817 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Apoptosis regulator Bcl X antibody
  • Apoptosis regulator Bcl X antibody
  • Apoptosis regulator Bcl-X antibody
  • Apoptosis regulator BclX antibody
  • B cell lymphoma 2 like antibody
  • B2CL1_HUMAN antibody
  • Bcl 2 like 1 antibody
  • Bcl 2 like 1 protein antibody
  • Bcl X antibody
  • Bcl xL antibody
  • Bcl xL antibody
  • BCL XL/S antibody
  • Bcl xS antibody
  • Bcl xS antibody
  • Bcl-2-like protein 1 antibody
  • Bcl2 Like 1 antibody
  • Bcl2 like1 antibody
  • Bcl2 like1 antibody
  • Bcl2 related gene antibody
  • Bcl2-L-1 antibody
  • BCL2L antibody
  • BCL2L1 antibody
  • BCL2L1 antibody
  • Bclx antibody
  • BclXL antibody
  • BclXs antibody
  • DKFZp781P2092 antibody
see all

Anti-BCL2L1 antibody [E18] images:

  Western blot - Bcl x antibody [E18] (ab32370)

Western blot - Bcl x antibody [E18] (ab32370)

Anti-BCL2L1 antibody [E18] (ab32370) at 1/1000 dilution + Jurkat cell lysate

Observed band size : 26 kDa (why is the actual band size different from the predicted?)

  Immunohistochemistry (Paraffin-embedded sections) - Bcl x antibody [E18] (ab32370)

Immunohistochemistry (Paraffin-embedded sections) - Bcl x antibody [E18] (ab32370)

Immunohistochemical analysis of human paraffin-embedded prostate carcinoma tissue using ab32370 at a 1/50 dilution.

  Western blot - BCL2L1 antibody [E18] (ab32370)

Western blot - BCL2L1 antibody [E18] (ab32370)

Anti-BCL2L1 antibody [E18] (ab32370) at 1/500 dilution + whole cell lysate prepared from a clinical sample of breast cancer cells at 20 µg

Secondary
Goat anti-rabbit IgG-HRP at 1/1000 dilution
developed using the ECL technique

Observed band size : 26 kDa (why is the actual band size different from the predicted?)


Exposure time : 15 minutes

Patient recieved anthracycline and taxane neoadjuvant chemotherapy.

Image courtesy of an anonymous Abreview.

See Abreview

References for Anti-BCL2L1 antibody [E18] (ab32370)

This product has been referenced in:

  • Hodgkinson VCet al. Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: A possible role for 14-3-3 theta/tau and tBID? J Proteomics : (2011).Read more (PubMed: 22115752) »
  • Medic S & Ziman M PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas). PLoS One 5:e9977 (2010). IHC-P; Human.Read more (PubMed: 20421967) »

See all 3 publications for this product

Publishing research using ab32370? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"